Raghunathan NJ, Korenstein D, Li QS, Tonorezos ES, Mao JJ. Determinants of mobile technology use and smartphone application interest in cancer patients. Cancer Med. 2018;7:5812--5819. 10.1002/cam4.1660

1. INTRODUCTION {#cam41660-sec-0005}
===============

There are more than 15.5 million cancer survivors in the United States and this number is expected to rise to 20.3 million by 2026.[1](#cam41660-bib-0001){ref-type="ref"} Optimal care for this population goes beyond cancer treatment to include supportive care services to address common symptoms such as pain,[2](#cam41660-bib-0002){ref-type="ref"} fatigue,[3](#cam41660-bib-0003){ref-type="ref"} insomnia[4](#cam41660-bib-0004){ref-type="ref"}, [5](#cam41660-bib-0005){ref-type="ref"}, and depressive symptoms.[6](#cam41660-bib-0006){ref-type="ref"} National Comprehensive Care Network (NCCN) guidelines for management of these symptoms recommend palliative care, cognitive behavioral therapy (CBT), mindfulness‐based stress reduction (MBSR), and supportive therapies. However, 30%‐60% of cancer patients have unmet supportive care needs[7](#cam41660-bib-0007){ref-type="ref"}, [8](#cam41660-bib-0008){ref-type="ref"} and these unmet needs may increase over time.[9](#cam41660-bib-0009){ref-type="ref"}

Utilization of supportive care services among cancer survivors is low, ranging from 2% to 50%.[7](#cam41660-bib-0007){ref-type="ref"}, [10](#cam41660-bib-0010){ref-type="ref"} Barriers to use of these services often include lack of provider referral and lack of awareness.[10](#cam41660-bib-0010){ref-type="ref"} Cancer patients have been shown to have significant need for education and information around survivorship.[11](#cam41660-bib-0011){ref-type="ref"}, [12](#cam41660-bib-0012){ref-type="ref"} To better inform survivors of supportive care services, optimization of information delivery is needed.

Optimal methods for information delivery to cancer survivors are not clear. Patients in rural areas have expressed a preference for electronic formats for ongoing contact[13](#cam41660-bib-0013){ref-type="ref"} but there is little evidence informing optimal delivery mechanisms and there are organizational challenges with electronic communication of health care.[14](#cam41660-bib-0014){ref-type="ref"} Newer technologies, such as mobile phones, have been rapidly adopted with 77% of American adults owning a smartphone, up from 35% in 2011.[15](#cam41660-bib-0015){ref-type="ref"} In a general population, it has been shown that interest in mobile technologies was associated with greater depression and worse quality of life as well as greater self‐efficacy.[16](#cam41660-bib-0016){ref-type="ref"} Other conditions, such as pregnancy,[17](#cam41660-bib-0017){ref-type="ref"} smoking cessation[18](#cam41660-bib-0018){ref-type="ref"}, and diabetes,[19](#cam41660-bib-0019){ref-type="ref"} have made use of mobile technologies to aid in information delivery in high‐need populations. Use of and interest in mobile technologies in the cancer survivor population specifically has not been described. These technologies are an opportunity for new and more efficient dissemination of supportive care information to cancer survivors.

Given the need for better information about symptom management among cancer survivors and the wide use of mobile technology, we set out to describe use and interest in smartphone applications for information delivery in the survivor population.

2. METHODS {#cam41660-sec-0006}
==========

2.1. Survey design and patients {#cam41660-sec-0007}
-------------------------------

We conducted a cross‐sectional survey study at the Abramson Cancer Center at the University of Pennsylvania in Philadelphia, PA, and Penn Cancer Network community hospitals in suburban and rural areas of Pennsylvania, New Jersey, and Delaware (Cape May Regional Hospital (Cape May, NJ); Chester Hospital (West Chester, PA); Community Medical Center (Toms River, NJ); Doylestown Hospital (Doylestown, PA); Kennedy Hospital, Kennedy Health Center (Cherry Hill, NJ); Kent General Hospital (Dover, DE); Lancaster General Health (Lancaster, PA); Milford Memorial Hospital (Milford, DE); Monmouth Medical Center (Longbranch, NJ); Pennsylvania Hospital (Philadelphia, PA); and Phoenixville Hospital (Phoenixville, PA) between December 2014 and September 2015. Research staff evaluated the eligibility criteria, approached patients during regular clinical visits, performed informed consent process and conducted the survey study. Patients were required to be 18 years of age or older, have a primary diagnosis of cancer, have a Karnofsky functional score of 60 or greater (ie ambulatory), understand written English, verbally indicate to the research staff that they felt physically well enough to complete a survey at the time of approach, and report experiencing nonzero pain (on a scale of 0‐10) in the last seven days. The Institutional Review Board of the University of Pennsylvania and the Scientific Review and Monitoring Committee of the Abramson Cancer Center approved the study protocol and surveys.

2.2. Outcomes {#cam41660-sec-0008}
-------------

Mobile technologies were defined as smartphones, tablets, or text messaging. Patients reported frequency of use on a 5‐point Likert scale---never, less than once/month, less than once/week, at least once/week and daily. We defined regular use as patient reported utilization at least once per week or daily.

Interest in smartphone applications for information delivery format was measured on a 4‐point Likert scale, from very unimportant to very important; we defined a given communication method as "of interest" if patients rated it as important or very important.

Patients self‐reported date of cancer diagnosis and demographic factors including age, sex, race, education, and marital status. We dichotomized education to high school or less and college or above. We determined cancer type and stage from chart abstractions and dichotomized stage to metastatic and non‐metastatic. Patients reported if they had received surgery, chemotherapy, and/or radiation.

2.3. Statistical analysis {#cam41660-sec-0009}
-------------------------

We performed statistical analysis using STATA software (Windows version 12.0, StatCorpLP, College Station, TX). We used univariate Chi^2^ testing to identify factors associated with mobile technology use and preference. We then conducted multivariate logistic regression analyses to identify factors associated with use and preference for mobile technology. We incorporated variables that were significant at *P* = 0.10 in the univariate Chi^2^ analysis. All analyses were two‐sided with p less than 0.05 indicating statistical significance in the multivariate model.

3. RESULTS {#cam41660-sec-0010}
==========

3.1. Demographics and clinical characteristics of study participants {#cam41660-sec-0011}
--------------------------------------------------------------------

Among the 631 participants, mean age was 60.3 years (range 23.1‐90.4), 415 (65.8%) were female, 521 (82.6%) white, 312 (53.8%) had non‐metastatic cancer, and approximately half (51.8%) were seen in community hospitals (Table [1](#cam41660-tbl-0001){ref-type="table"}). Most (n = 427, 68.2%) had completed at least some time in college, and 65.8% (n = 415) reported they were married or currently living with a partner. The most common cancer types were breast (n = 202, 32%), followed by thoracic, hematologic, and gastrointestinal. Nearly half (n = 303, 49.6%) of patients had been diagnosed in the 12 months prior to completing the survey, with 20.6% (n = 126) diagnosed within 12 to 36 months; 182 (29.8%) had been diagnosed more than 36 months before taking the survey. Most (n = 556, 88.1%) were treated with chemotherapy and about half had received surgery (n = 336, 53.3%) and radiation (n = 335, 53.1%).

###### 

Characteristics of all survey participants (N = 631)

  Characteristic                N     \%
  ----------------------------- ----- ------
  Age                                 
  \>65                          225   35.7
  56‐65                         200   31.7
  46‐55                         136   21.6
  ≤45                           70    11.1
  Sex                                 
  Female                        415   65.8
  Male                          216   34.2
  Race                                
  White                         521   82.6
  Non‐White                     110   17.4
  Education                           
  High school or less           199   31.8
  College or above              427   68.2
  Marital Status                      
  Not married                   216   34.2
  Married/living with partner   415   65.8
  Cancer type                         
  Breast                        202   32.0
  Gastro‐Intestinal             81    12.8
  Genito‐Urinary                36    5.7
  Gynecologic                   47    7.5
  Head/Neck                     53    8.4
  Hematologic                   93    14.7
  Thoracic                      93    14.7
  Other                         26    4.1
  Cancer stage                        
  Non‐metastatic                312   53.8
  Metastatic                    268   46.2
  Time since diagnosis                
  ≤12 mo                        303   49.6
  12‐36 mo                      126   20.6
  \>36 mo                       182   29.8
  Surgery                             
  No                            295   46.7
  Yes                           336   53.3
  Chemotherapy                        
  No                            75    11.9
  Yes                           556   88.1
  Radiation                           
  No                            296   46.9
  Yes                           335   53.1
  Worst pain                          
  Mild                          170   27.1
  Moderate                      148   23.6
  Severe                        309   49.3
  Location of treatment               
  Academic hospital             304   48.2
  Community hospital            327   51.8
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3.2. Use and determinants of use of mobile technologies {#cam41660-sec-0012}
-------------------------------------------------------

Among 631 respondents, 466 (73.9%) regularly used mobile technologies including smartphones (n = 356, 57%), tablets (n = 240, 38%), and text messaging (n = 418, 66%). Younger patients were more likely to report regular use of mobile technologies (91.4% for age ≤45 years, 89.0% for age 46‐55, 78.5% for age 56‐65 and 55.1% for age \> 65) (Table [2](#cam41660-tbl-0002){ref-type="table"}). In addition, patients with at least some college education (79.6% vs 60.8% with high school education or less, *P* \< 0.001), women (76.4% vs 69.0% of men, *P* = 0.045), and patients seen at an academic hospital (78.9% vs 69.1% of those treated at community hospitals, *P* = 0.005) were more likely to report regular use of mobile technologies. In multivariate analysis, patients under 45 years old were substantially more likely to use mobile technologies (\[AOR\] 6.8, 2.8‐16.9 95% CI, *P* \< 0.001) than those aged older than 65 years (Table [3](#cam41660-tbl-0003){ref-type="table"}). Those with college or above education were also more likely to use mobile technologies than those with high school education or less (AOR 2.3, 1.5‐3.5 95% CI, *P* \< 0.001). There was no difference in mobile technology use across races.

###### 

Demographic/clinical factors and mobile device use and smartphone application interest

  Characteristic                Mobile device usage   Smartphone interest                               
  ----------------------------- --------------------- --------------------- ------------- ------ ------ -------------
  Age                                                                                                   
  \>65                          124                   55.1                  **\<0.001**   61     28.0   **\<0.001**
  56‐65                         157                   78.5                  70            35.4          
  46‐55                         121                   89.0                  69            51.1          
  ≤45                           64                    91.4                  42            60.0          
  Sex                                                                                                   
  Female                        317                   76.4                  **0.045**     155    37.9   0.45
  Male                          149                   69.0                  87            41.0          
  Race                                                                                                  
  White                         383                   73.5                  0.67          175    34.0   **\<0.001**
  Non‐White                     83                    75.5                  67            63.2          
  Education                                                                                             
  High school or less           121                   60.8                  **\<0.001**   65     32.8   **0.036**
  College or above              340                   79.6                  174           41.6          
  Marital Status                                                                                        
  Not married                   147                   68.1                  **0.017**     84     39.4   0.86
  Married/living with partner   319                   76.9                  158           38.7          
  Cancer type                                                                                           
  Breast                        164                   81.2                  **0.010**     80     40.0   0.24
  Gastro‐intestinal             65                    80.2                  37            45.7          
  Genito‐urinary                28                    77.8                  17            47.2          
  Gynecologic                   34                    72.3                  18            39.1          
  Head/Neck                     39                    73.6                  15            29.4          
  Hematologic                   59                    63.4                  31            34.8          
  Thoracic                      59                    63.4                  30            32.6          
  Other                         18                    69.2                  14            53.8          
  Cancer Stage                                                                                          
  Non‐metastatic                236                   75.6                  0.43          118    38.6   0.91
  Metastatic                    195                   72.8                  103           39.0          
  Time since diagnosis                                                                                  
  \<12 mo                       216                   71.3                  0.16          114    37.9   0.88
  12‐36 mo                      101                   80.2                  49            39.8          
  \>36 mo                       136                   74.7                  71            39.9          
  Treatment---surgery                                                                                   
  No                            195                   66.1                  **\<0.001**   101    34.7   **0.041**
  Yes                           271                   80.6                  141           42.7          
  Treatment---chemotherapy                                                                              
  No                            52                    69.3                  0.34          33     44.0   0.34
  Yes                           414                   74.5                  209           38.3          
  Treatment---radiation                                                                                 
  No                            217                   73.3                  0.77          116    40.1   0.58
  Yes                           249                   74.3                  126           37.9          
  Worst pain                                                                                            
  Mild                          128                   75.3                  0.26          57     34.8   0.18
  Moderate                      115                   77.7                  66            44.9          
  Severe                        219                   70.9                  117           38.2          
  Location of treatment                                                                                 
  Academic hospital             240                   78.9                  **0.005**     128    43.0   0.051
  Community hospital            226                   69.1                  114           35.3          

Values found to be significant to *P* \< 0.05 are bolded.
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###### 

Multivariate analysis of mobile device use and smartphone interest

                                Mobile device usage   Smartphone Interest                   
  ----------------------------- --------------------- --------------------- --------------- -------------
  Age                                                                                       
  \>65                          1                                           1               
  56‐65                         2.8 (1.8‐4.4)         **\<0.001**           1.2 (0.8‐1.9)   0.33
  46‐55                         6.2 (3.3‐11.5)        **\<0.001**           2.7 (1.6‐4.3)   **\<0.001**
  ≤45                           6.8 (2.8‐16.9)        **\<0.001**           3.2 (1.7‐5.9)   **\<0.001**
  Sex                                                                                       
  Female                        1                                           1               
  Male                          0.7 (0.5‐1.1)         0.16                  1.6 (1.1‐2.4)   **0.016**
  Race                                                                                      
  White                         1                                           1               
  Non‐white                     0.9 (0.5‐1.6)         0.72                  3.4 (2.1‐5.5)   **\<0.001**
  Education                                                                                 
  High school or less           1                                           1               
  College or above              2.3 (1.5‐3.5)         **\<0.001**           1.4 (1.0‐2.1)   0.076
  Marital Status                                                                            
  Not married                   1                                           1               
  Married/living with partner   1.6 (1.0‐2.4)         **0.032**             1.0 (0.7‐1.5)   1
  Treatment---surgery                                                                       
  No                            1                                           1               
  Yes                           1.6 (1.1‐2.4)         **0.022**             1.5 (1.1‐2.2)   **0.021**
  Location of treatment                                                                     
  Academic hospital             1                                           1               
  Community hospital            0.8 (0.6‐1.3)         0.43                  1.0 (0.7‐1.4)   0.99

Values found to be significant to *P* \< 0.05 are bolded.
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3.3. Determinants of interest in smartphone applications {#cam41660-sec-0013}
--------------------------------------------------------

Overall, 242 (39%) patients expressed interest in smartphone applications to learn about supportive care services, with more younger patients reporting this interest (60.0% for age ≤45 vs 28.0% for age \>65, *P* \< 0.001). There was no significant difference in interest between genders, with 37.9% of women and 41.0% of men expressing interest in information delivery via smartphone application (*P* = 0.45). Interest varied by race with 34.0% of white patients and 63.2% of non‐white patients expressing interest in information delivery of supportive care services by smartphone application (*P* \< 0.001). Of those with a high school education or less, 32.8% expressed an interest in smartphone application‐delivered information compared with while 41.6% of those with college or above (*P* = 0.036; Table [2](#cam41660-tbl-0002){ref-type="table"}).

In multivariate logistic analysis, younger age (AOR 3.2 for age ≤45 compared to \>65, 1.7‐5.9 95% CI, *P* \< 0.001), non‐white race (AOR 3.4, 2.1‐5.5 95% CI, *P* \< 0.001), and male gender (AOR 1.6, 1.1‐2.4 95% CI, *P* = 0.016) were associated with an interest in receiving supportive care information through smartphone applications. Interest in information via smartphone app was similar across education groups (Table [3](#cam41660-tbl-0003){ref-type="table"}).

4. DISCUSSION {#cam41660-sec-0014}
=============

Our data demonstrate high levels of mobile technology use, particularly among younger cancer survivors. Non‐white patients, younger patients and male patients reported more interest in delivery of information through smartphone applications. While overall mobile technology use is similar to that reported for the general population,[15](#cam41660-bib-0015){ref-type="ref"} variations in interest and reported use among patients have implications for the design of mobile technology approaches to information delivery regarding supportive care.

Adolescent and young adult cancer patients have been found to have poorer physical and emotional well‐being compared to healthy controls.[20](#cam41660-bib-0020){ref-type="ref"} Greater awareness of supportive care services could ameliorate this outcome. It is not surprising to find younger patients have an interest in smartphone applications for the delivery of important information regarding supportive care services. In the adolescent and young adult (AYA) population, the proportion reporting smartphone use approaches 94%.[15](#cam41660-bib-0015){ref-type="ref"} Many may not remember a time before the internet and smartphones.[21](#cam41660-bib-0021){ref-type="ref"} Though the AYA survivor often uses mobile and internet technology to guide healthy behaviors, Mooney et al[22](#cam41660-bib-0022){ref-type="ref"} showed that much of the information they found did not meet their needs. Our results encourage further evaluation of mobile applications to educate this less‐informed population about potential supportive care interventions.

Our findings with regards to race are interesting and are reflective of other studies. In a national telephone survey study of cancer information seeking behavior, social determinants of race, ethnicity and social class affected preference for information sources.[23](#cam41660-bib-0023){ref-type="ref"} It is known that non‐white cancer survivors experience lower health‐related quality of life (HRQOL),[24](#cam41660-bib-0024){ref-type="ref"} are more likely to be obese[25](#cam41660-bib-0025){ref-type="ref"} and experience a physical limitation[26](#cam41660-bib-0026){ref-type="ref"} and poorer patient‐provider communication.[27](#cam41660-bib-0027){ref-type="ref"} More specific communications tailored to characteristics such gender, language, health literacy, and culture may improve uptake of recommended interventions.[28](#cam41660-bib-0028){ref-type="ref"}, [29](#cam41660-bib-0029){ref-type="ref"}, [30](#cam41660-bib-0030){ref-type="ref"} Our study shows a significant interest in smartphone applications, particularly in a non‐white population. Increased use of technology, such as online patient portals, for communication[31](#cam41660-bib-0031){ref-type="ref"}, [32](#cam41660-bib-0032){ref-type="ref"} indicates potential to utilize mobile technology to increase awareness of supportive care services, decrease barriers, and improve health outcomes in cancer patients.

There are several limitations to our study. In this survey‐based study, there is the potential for recall bias and results should be interpreted with caution. However, survey responses regarding preference require little recall and are relevant for guiding information delivery. Selection bias is possible although our recruitment across academic and community centers and high response rate are reassuring. The survey tool was developed and administered in an English‐speaking population, which may lead to underrepresentation of certain cultural groups and results may not be generalizable to a non‐English speaking population. Nonetheless, our study indicates there are differences among a general cancer population in mobile technology use and smartphone application interest.

Our results point to an interest in information delivery via smartphone applications, particularly in younger and non‐white populations. There is still a gap in understanding why there is an interest in mobile technology for information delivery and how to further improve smartphone applications to serve in supportive care. With further research, our findings suggest it is possible to optimize mobile technology to aid in delivery of evidence‐based recommendations to underserved populations.
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